MO631: Diabetic Retinopathy and/or Diabetic Nephropathy Confers A Worse Renal Prognosis. (3rd May 2022)

• Record Type: Journal Article
• Authors: Bermejo Garcia, Sheila; Agraz, Irene; Vergara, Ander; Bestard, Oriol; Jose Soler Romeo, Maria
• Is Part Of: Nephrology dialysis transplantation. Volume 37(2022)Supplement 3
• Publication Date: 2022-05-03
• Subjects: Nephrology -- Periodicals; Hemodialysis -- Periodicals; Kidneys -- Transplantation -- Periodicals; Hemodialysis; Kidneys -- Transplantation; Nephrology; Periodicals; 616.61
• DOI: 10.1093/ndt/gfac076.024
• Languages: English
• ISSNs: 0931-0509

Abstract

Abstract: BACKGROUND AND AIMS: Around 50%–60% lesions of non-diabetic nephropathy (NDN) have been identified in patients with diabetes and renal biopsy. NDN patients have a better renal prognosis and survival. Diabetic retinopathy (DR) is a microvascular complication of diabetes frequently associated with diabetic nephropathy (DN). The objective of the work is to study the renal prognosis and survival of patients with DN with or without DR. METHOD: Retrospective, observational, multicenter study of the pathological results of diabetic patients with renal biopsy was undertaken. A total of 18 Spanish centers have participated. RESULTS: Cohort of 832 patients: 621 men (74.6%), median age 61.7 ± 12.8 years, median creatinine 2.8 ± 2.2 mg/dL and proteinuria 2.7 (1.2–5.4) g/24 h. Of them, 26.6% ( n = 221) presented DR, 18.8% ( n = 156) peripheral vasculopathy and 17.7% ( n = 147) ischemic heart disease. On biopsy, 39.5% ( n = 329) of patients had DN, 413 (49.6%) NDN and 90 (10.8%) mixed forms. We evidenced more DR in the DN group compared with the other two groups (44.1% versus 11.1% in NDN and 33.3% in mixed forms). Regarding renal prognosis, 58.9% ( n = 109) of patients with DR and DN and mixed forms required RRT versus 40.7% ( n = 88) of patients without DR. A total of 39.1% ( n = 18) of patients with DR and NDN required renal replacement therapy (RRT) versus 23.9% ( n = 79) of patients without DR. Regarding mortality, 28.6% ( n = 50) of patients with DR and DN or mixed forms died during the follow-up versus 22.7% ( n = 49) of patients without DR. A total of 15.2% ( n = 7) of patients with DR and NDN died and 15.4% ( n = 51) of patients without DR. In survival analysis (Kaplan—Meier curves), patients with DR had worse renal prognosis (P < 0.001), patients with DN (P < 0.001) and patients with DR and/or DN and mixed forms (P = 0.02). Cox regression analysis identified as independent risk factors of RRT: age (OR 1.014;1.025–1.004, P = 0.006), creatinine (OR 1.262; 1.217–1.309; P < 0.001), proteinuria (OR 1.057; 1.03–1.085; P < 0.001), DR (OR 1.359; 1.007–1.833; P = 0.045), DR and/or DN (OR 1.59; 2.42–1.04; P = 0.033) and DN (OR1.489; 1.05–2.11; P = 0.026). CONCLUSION: The presence of DR and/or DN confers a worse renal prognosis. The diagnosis of diabetic microangiopathy in terms of retinopathy and/or diabetic nephropathy is crucial since it confers a worse renal prognosis indicating patients at risk of progression to end-stage renal disease.